Powered by: Motilal Oswal
2025-09-07 11:27:06 am | Source: Motilal Oswal Financial Services Ltd
Neutral Alkyl Amines Chemicals Ltd for the Target Rs. 2,270 by Motilal Oswal Financial Services Ltd
Neutral Alkyl Amines Chemicals Ltd for the Target Rs. 2,270 by Motilal Oswal Financial Services Ltd

Macro headwinds balanced by expansion and innovation

Earnings below our estimate

  • Alkyl Amines Chemicals (AACL) reported a muted operating performance in 1QFY26 as EBITDA declined 3% YoY. Gross margin contracted 120bp YoY to 45.8%. Employee expenses increased by 30bp YoY to 7% YoY, while other expenses declined 60bp YoY to 20%.
  • The company is expanding capacities, introducing new products, and upgrading manufacturing facilities. These initiatives are supported by inhouse R&D focused on enhancing quality and achieving cost efficiencies. In FY26, AACL aims to prioritize sustainable growth through increasing market share in existing products and launching new offerings.
  • We broadly maintain our FY26/27 estimates, supported by the ramp-up of the newly commercialized plant, initiatives to increase market share in existing products, and new offerings. We value the stock at 45x FY27E EPS to arrive at a TP of INR2,270. Reiterate Neutral.

Muted operating performance

  • Revenue grew 1% YoY to INR4b (est. INR4.2b), while gross margin contracted by 120bp YoY to 45.8%.
  • EBITDA margins contacted 90bp YoY to 18.9% (est. 18.6%). Employee costs as a percentage of sales stood at 7% (vs. 6% in 1QFY26), while other expenses stood at 20% vs. 21% in 1QFY25.
  • EBITDA stood at INR766m, down 3% YoY (est. of INR784m). .
  • Adj. PAT stood at INR494m, up 1% YoY (est. of INR528m).

Valuation and view

  • AACL remains focused on strengthening its global presence by developing efficient, cost-effective processes for high-grade and extra-pure specialty products, enhancing the efficiency of existing processes, and exploring emerging process intensification techniques for both new and existing products.
  • We estimate a CAGR of 10%/16%/18% in revenue/EBITDA/PAT over FY26-27. The key risk to our outlook is high competition (domestic and imports, mainly from China), leading to limited pricing power. .
  • We largely maintain our FY26/FY27 estimates and value the stock at 45x FY27E EPS to arrive at a TP of INR2,270. Reiterate Neutral.

 

For More Research Reports : Click Here 

For More Motilal Oswal Securities Ltd Disclaimer
http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html
SEBI Registration number is INH000000412

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here